Clinical and radiological diagnosis of neurocysticercosis: A case report;Diagnóstico clínico-radiológico de neurocisticercosis: A propósito de un caso

Anales del Sistema Sanitario de Navarra

Volumn 32, Issue 2, 2009, Pages 269-273

  Navarro González, David ^a,c   Huarte, I ^a   Santesteban, R ^a   Bidarte, M ^a   Ayechu, A ^b  

^a Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c Comunidad de La Rioja 1 3C ^*  (Spain)

Author keywords

Albendazole; Epilepsy; Immigrant; Neurocysticercosis; Taenia solium

Indexed keywords

ALBENDAZOLE; CORTICOSTEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONVULSION; FEMALE; HOSPITAL ADMISSION; HUMAN; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS;

ADULT; FEMALE; HUMANS; NEUROCYSTICERCOSIS;

EID: 70349091885     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. DEL BRUTTO OH. Neurocysticercosis: up-dating in diagnosis and treatment. Neurología 2005; 20: 412-418.
2. IMIRIZALDU L, MIRANDA L, GARCíA-GURTUBAY I, GASTóN I, URRIZA J, QUESADA P. Neurocisticercosis. Una enfermedad emergente. An Sist Sanit Navar 2004; 27: 201-209.
3. GARCíA-ALBEA E. Cisticercosis en España. Algunos datos epidemiológicos. Rev Clin Esp 1989; 184: 3-6.
4. MITCHELL WG, CRAWFORD TO. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics 1988; 82: 76-82. (Pubitemid 18164079)
5. ENGELS D, URBANI C, BELOTTO A, MESLIN F, SAVIOLI L. The control of human (neuro) cysticercosis: Which way forward? Acta Trop 2003; 87: 177-182.
6. ROCA C, GASCÓN J, FONT B, PUJOL T, VALLS ME, CORACHáN M. Neurocysticercosis and population movements: analysis of 23 imported cases in Spain. Eur J Clin Microbiol Infect Dis 2003; 22: 382-384.
7. TERRAZA S, PUJOL T, GASCON J, CORACHAN M. Neurocysticercosis: an imported disease? Med Clin 2001; 116: 261-263.
8. JUNYENT M, NúñEZ S, MIRó O. Urgencias médicas del inmigrante adulto. An Sist Sanit Navar 2006; 29 (Suppl 1): 27-34.
9. WHITE A. (1997). Neuroysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997; 24: 101-115.
10. FERRER E. Taeniasis/cysticercosis: Epidemiology and control. Advances in vaccine production. Bol Mal Salud Amb 2005; 45: 89-99.
11. SOTELO J, DEL BRUTTO OH. Review of neurocysticerocis. Neurourg Focus 2002; 12: 1-7.
12. GARCÍA HH, DEL BRUTTO OH, NASH TE, WHITE AC JR, TSANG VC, GILMAN RH. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 2005; 72: 3-9.
13. DEL BRUTTO OH, RAJSHEKHAR V, WHITE AC JR, TSANG VC, NASH TE, TAKAYANAGUI OM et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57: 177-183.
14. ESCOBEDO F, SOTELO J, PENAGOS P, RODRIGUEZ J, DEL BRUTTO O. Albendazole therapy for human neurocysticerosis, a controlled study with computerized tomography and magnetic resonante. Acta Leiden 1989; 57: 247-254.
15. SOTELO J, DEL BRUTTO OH, PENAGOS P, ESCOBEDO F, TORRES B, RODRÍGUEZ-CARBAJAL J et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cisticercosis. J Neurol 1990; 237: 69-72.
16. GARCÍA HH, GILMAN RH, HORTON J, MARTÍNEZ M, HERRERA G, ALTAMIRANO J et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 vs 14 days of treatment. Neurology 1997; 48: 1421-1427. (Pubitemid 27240575)
17. NASH TE, DEL BRUTTO OH, BUTMAN JA, CORONA T, DELGADO-ESCUELA A, DURON RM et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004; 62: 1934-1938.
18. HAWK MW, SHAHLAIE K, KIM KD, THEIS JH. Neurocysticercosis: a review. Surg Neurol 2005; 63: 123-132.
19. FERRER E. Taeniasis/cysticercosis: epidemiology and control. Advances in vaccine production. Bol Mal Salud Amb 2005; 45: 89-99.
20. PÉREZ-LÓPEZ C, ISLA-GUERRERO A, ÁLVAREZ F, BUDKE M, FERNÁNDEZ-MIRANDA JC, PAZ JF ET AL. Actualización en el tratamiento de la neurocisticercosis. Rev Neurol 2003; 36: 805-811.